Obstructive sleep apnea (OSA) is highly prevalent among patients with metabolic dysfunction-associated steatotic liver ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Research led by Korea University Ansan Hospital reports finding an association between moderate to severe obstructive sleep apnea and increased risk of cerebral microbleeds. Subscribe to our ...

Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.

Zepbound, Eli Lilly’s weight loss medication, became the first FDA-approved drug for obstructive sleep apnea Dec. 20. The new indication is for obese adults who experience moderate to severe ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In this video, a speaker at the ACP Internal Medicine Meeting recaps his talk on hot topics and ...

Tirzepatide (Zepbound and Mounjaro), which is approved for chronic weight management and treatment of type 2 diabetes, has significant benefits for patients with moderate-to-severe obstructive sleep ...

Eli Lilly and Co. announced promising results for its weight-loss drug Zepbound, indicating its potential as a treatment for sleep apnea. The drug demonstrated effectiveness in reducing the severity ...

We're all chasing better rest. From herbal teas and nighttime routines to white noise machines and tracking apps, quality sleep is now a key part of the wellness conversation. But for people with ...

The market is rapidly growing due to rising sleep disorder prevalence, increasing demand for remote monitoring, and ...